Nicholas Tarricone, MD
Obstetrics & Gynecology · Rockville Centre, NYNPI 1255371449
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $15,979 of the $25,604 with a category attached, or 62.4%. Astellas Pharma US Inc accounts for 97.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $9,614 and has fallen 99.7% since, to $30 in 2025. Among obstetrics & gynecology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 29 payments — averaging $882.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$25K
- Myovant Sciences Inc.$244
- AbbVie$241
- Aspira Women's Health Inc$66
- Coopersurgical, Inc.$63
- KARL Storz Endoscopy-america$30
What the payments were for
- Consulting fees$15,97962%
- Speaking & faculty fees$6,31525%
- Travel & lodging$1,7167%
- Food & beverage$1,5796%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 18 | $24,960 |
| Myovant Sciences Inc. | 2 | $244 |
| AbbVie | 4 | $241 |
| Aspira Women's Health Inc | 1 | $66 |
| Coopersurgical, Inc. | 3 | $63 |
| KARL Storz Endoscopy-america | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$25,604 in reported general payments places this provider in the 95th percentile of 2,673 obstetrics & gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| YuvafemEstradiol | 84 | $15,328 |
| Estradiol | 45 | $8,540 |
| PremarinEstrogens, Conjugated | 15 | $7,119 |
| Raloxifene Hcl | 90 | $3,311 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 78 | $1,543 |
| ValacyclovirValacyclovir Hcl | 33 | $1,234 |
| Solifenacin Succinate | 12 | $1,072 |
| Oxybutynin Chloride ErOxybutynin Chloride | 19 | $465 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 23 | $314 |
| Fluconazole | 54 | $270 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $15 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Rockville Centre
- Mary PolanNew York$862K
- Steven GoldsteinNew York$551K
- Veronica LernerNew York$368K
- Lisa EngNew York$219K
- Theodore GoldmanEast Northport$213K
- Miriam CremerBrooklyn$196K
- Rachel MaschNew York$187K
- Amy PollackNew York$184K
- Jian Qun HuangNew York$160K
- Carolyn WesthoffNew York$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.